AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
AS Latvijas Juras medicinas centrs had a gross margin of 5.06% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
AS Latvijas Juras medicinas centrs Gross Margin % Related Terms
AS Latvijas Juras medicinas centrs Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AS Latvijas Juras medicinas centrs Gross Margin % Chart
ORSE:LJM1R vs HCA, THC, ENSG: Gross Margin % Comparison
For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AS Latvijas Juras medicinas centrs Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's Gross Margin % distribution charts can be found below:
* The bar in red indicates where AS Latvijas Juras medicinas centrs's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a Gross Margin % of 5.06% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on AS Latvijas Juras medicinas centrs and its competitors. This is 28% below median its historical median of 7.06. Over the past decade, AS Latvijas Juras medicinas centrs' Gross Margin % has ranged from 3.13 to 13.00.
Is AS Latvijas Juras medicinas centrs' Gross Margin % too high?
AS Latvijas Juras medicinas centrs' current Gross Margin % of 5.06% is 28% below median its 10-year median of 7.06. Over the past 10 years, this metric has ranged from a low of 3.13 to a high of 13.00. The Healthcare Providers & Services industry median Gross Margin % is 40.01. AS Latvijas Juras medicinas centrs' value of 5.06% is 87.4% below this industry median. Overall, AS Latvijas Juras medicinas centrs has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does AS Latvijas Juras medicinas centrs' Gross Margin % compare to HCA and THC?
AS Latvijas Juras medicinas centrs' Gross Margin % of 5.06% can be compared against companies in the Healthcare Providers & Services industry. The industry median Gross Margin % is 40.01. AS Latvijas Juras medicinas centrs' value of 5.06% is 87.4% below this benchmark. Historically, AS Latvijas Juras medicinas centrs' own Gross Margin % has ranged from 3.13 to 13.00 over the past decade. While the company's 10-year median is 7.06 vs. the industry median of 40.01, AS Latvijas Juras medicinas centrs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.01, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AS Latvijas Juras medicinas centrs's current Gross Margin % of 5.06% is 87.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on AS Latvijas Juras medicinas centrs and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AS Latvijas Juras medicinas centrs's current Gross Margin % is 5.06%, which is 28% below median its own 10-year median of 7.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AS Latvijas Juras medicinas centrs stock overvalued right now?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a current Gross Margin % of 5.06%. The stock's GF Value™ is €7.78, compared to a current price of €7.80 — trading 0.3% above its estimated fair value. The current Gross Margin % is 5.06%, which is 28% below median its 10-year median of 7.06 and 87.4% below the Healthcare Providers & Services industry median of 40.01. AS Latvijas Juras medicinas centrs' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For AS Latvijas Juras medicinas centrs (ORSE:LJM1R), the current Gross Margin % is 5.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?
Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued.
The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.
Key valuation signals for ORSE:LJM1R:
Gross Margin %: 5.06% (28% below median its 10-year median of 7.06)
GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
Industry Position: 87.4% below the Healthcare Providers & Services median
No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AS Latvijas Juras medicinas centrs Business Description
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score
Get the complete analysis for ORSE:LJM1R
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORSE:LJM1R has been successfully added to your 
